Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy

被引：0
|
作者：
Sara Small
Shuo Ma
机构：
[1] Northwestern University,Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
CLL; SLL; BTK inhibitor; Bcl-2 inhibitor; PI3K inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：325 / 335
页数：10
相关论文
共 50 条
  • [41] Frequency of 5′ IGH deletions in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Nooraie, F.
    Quintero-Rivera, F.
    Rao, P. N.
    CYTOGENETIC AND GENOME RESEARCH, 2008, 121 (01)
  • [42] Plasmacytoid Differentiation in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Is Common and Enhanced in Proliferation Centers (PC)
    Moore, Erika
    Swerdlow, Steven
    Gibson, Sarah
    LABORATORY INVESTIGATION, 2015, 95 : 366A - 366A
  • [43] Evaluation of paraffin reactive CD5 antibody in chronic lymphocytic leukemia (CLL) small lymphocytic lymphoma (SLL).
    Ng, BT
    Ingle, R
    Brien, TP
    Purdy, S
    Sheehan, CE
    Ross, JS
    Nazeer, T
    MODERN PATHOLOGY, 1998, 11 (01) : 137A - 137A
  • [44] CD38 and CD138 expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Kampalath, B
    Novoa-Takara, L
    Rao, N
    Shidham, VB
    Chang, CC
    MODERN PATHOLOGY, 2003, 16 (01) : 238A - 238A
  • [45] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Reed-Sternberg-Like Cells and Classic Hodgkin Lymphoma Transformation of CLL/SLL: Does This Distinction Matter?
    Gupta, Alia
    Kurtin, Paul
    Parikh, Sameer
    King, Rebecca
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 837 - 838
  • [46] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Reed-Sternberg-Like Cells and Classic Hodgkin Lymphoma Transformation of CLL/SLL: Does This Distinction Matter?
    Gupta, Alia
    Kurtin, Paul
    Parikh, Sameer
    King, Rebecca
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 837 - 838
  • [47] Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)
    Khelifi, Rania S.
    Huang, Steven J. T.
    Savage, Kerry J.
    Villa, Diego
    Scott, David W.
    Ramadan, Khaled
    Connors, Joseph M.
    Sehn, Laurie H.
    Toze, Cynthia L.
    Gerrie, Alina S.
    BLOOD, 2020, 136
  • [48] Treatment-Related Myeloid Neoplasms Secondary to Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Clinicopathologic Study of 8 Cases
    Stoecker, M. M.
    Huang, Q.
    Boswell, E. L.
    Wang, E.
    LABORATORY INVESTIGATION, 2012, 92 : 373A - 373A
  • [49] Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length
    Ammann, Eric M.
    Shanafelt, Tait D.
    Wright, Kara B.
    McDowell, Bradley D.
    Link, Brian K.
    Chrischilles, Elizabeth A.
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 643 - 649
  • [50] Evidence of low incidence of myelodysplastic syndrome (MDS) in patients exposed to bendamustine treatment for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
    Burke, John M.
    Bibeau, Kristen
    Kahl, Brad
    Carson, Kenneth R.
    Zelenetz, Andrew D.
    Brander, Danielle M.
    Maddocks, Kami J.
    Gerecitano, John F.
    Pathak, Ashutosh K.
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345